{"id":"https://openalex.org/W4396587601","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po3-19-06","title":"Abstract PO3-19-06: MRD Assay evaluates Recurrence and response via a tumor Informed Assessment: MARIA-Breast Observational Trial","display_name":"Abstract PO3-19-06: MRD Assay evaluates Recurrence and response via a tumor Informed Assessment: MARIA-Breast Observational Trial","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396587601","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po3-19-06"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-po3-19-06","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po3-19-06","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po3-19-06","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003631861","display_name":"Edward D. Esplin","orcid":"https://orcid.org/0000-0001-9205-3756","observed_orcids":["https://orcid.org/0000-0001-9205-3756"]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Esplin","raw_affiliation_strings":["1Invitae, San Francisco, California, United States,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Invitae, San Francisco, California, United States,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073062103","display_name":"Kelli Swan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelli Swan","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092084255","display_name":"Lee Ifhar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee Ifhar","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048576424","display_name":"Brandie Heald","orcid":"https://orcid.org/0000-0003-4227-3675","observed_orcids":["https://orcid.org/0000-0003-4227-3675"]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandie Heald","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032695297","display_name":"Sarah M. Nielsen","orcid":"https://orcid.org/0000-0002-5916-6393","observed_orcids":["https://orcid.org/0000-0002-5916-6393"]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Nielsen","raw_affiliation_strings":["3Invitae, California, United States,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Invitae, California, United States,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067787556","display_name":"Daniel Pineda\u2010Alvarez","orcid":"https://orcid.org/0000-0002-0580-058X","observed_orcids":["https://orcid.org/0000-0002-0580-058X"]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Pineda-Alvarez","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William O'Callaghan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William O'Callaghan","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024292903","display_name":"Robert D. Daber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Daber","raw_affiliation_strings":["2Invitae,","Invitae,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Invitae,","institution_ids":["https://openalex.org/I4210160571"]},{"raw_affiliation_string":"Invitae,","institution_ids":["https://openalex.org/I4210160571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034967242","display_name":"Darrel Ross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darrel Ross","raw_affiliation_strings":["4Onslow Radiation Oncology, Jacksonville, North Carolina, United States,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Onslow Radiation Oncology, Jacksonville, North Carolina, United States,","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Carlos Vieira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124469","display_name":"Columbus Regional Healthcare System","ror":"https://ror.org/02vn2vd34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124469"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Vieira","raw_affiliation_strings":["5Columbus Regional Health, Columbus, Indiana, United States,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Columbus Regional Health, Columbus, Indiana, United States,","institution_ids":["https://openalex.org/I4210124469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070207276","display_name":"Aadel A. Chaudhuri","orcid":"https://orcid.org/0000-0003-3115-3061","observed_orcids":["https://orcid.org/0000-0003-3115-3061"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aadel Chaudhuri","raw_affiliation_strings":["6Washington University School of Medicine, St. Louis, Missouri, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Washington University School of Medicine, St. Louis, Missouri, United States","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040325455","display_name":"Wolfgang Michael Korn","orcid":"https://orcid.org/0000-0002-0124-6841","observed_orcids":["https://orcid.org/0000-0002-0124-6841"]},"institutions":[{"id":"https://openalex.org/I4210160571","display_name":"Invitae (United States)","ror":"https://ror.org/05mt7ye26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210160571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Korn","raw_affiliation_strings":["1Invitae, San Francisco, California, United States,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Invitae, San Francisco, California, United States,","institution_ids":["https://openalex.org/I4210160571"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PO3","last_page":"19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9660000205039978},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9610000252723694},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/recurrence-prediction","display_name":"recurrence prediction","score":0.6010000109672546},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9710000157356262},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6840000152587891},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/curative-intent-surgery","display_name":"curative-intent surgery","score":0.4950000047683716},{"id":"https://openalex.org/keywords/clinical-decision-making","display_name":"clinical decision-making","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7392290830612183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7253491282463074},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6096269488334656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4936105012893677},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.41706371307373047},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12273988127708435}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-po3-19-06","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po3-19-06","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po3-19-06","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379284495","https://openalex.org/W4282967264","https://openalex.org/W4416958420","https://openalex.org/W4399667448","https://openalex.org/W4408729495","https://openalex.org/W4389287531","https://openalex.org/W4322769648","https://openalex.org/W7162569530","https://openalex.org/W3172019519","https://openalex.org/W4411287742"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Detectable":[2],"ctDNA":[3,72,92,107,192,219,261],"in":[4,20,49,73,148,173,262,346],"patients":[5,147,179],"with":[6,12,51,123,180,223,317,340],"solid":[7],"tumors":[8],"has":[9,79,118,140],"been":[10,119],"associated":[11],"disease":[13,26,102],"prognosis":[14],"pre-treatment,":[15],"assessing":[16],"response":[17,126,386],"to":[18,56,62,121,197,202,300,306,313,325,330],"therapy":[19,213],"the":[21,52,151,174,237,248,275,302,322,335,399],"form":[22],"of":[23,41,67,91,101,114,150,154,177,247,257,282,284,304,327,332,337,398],"minimal":[24],"residual":[25],"(MRD),":[27],"and":[28,117,136,216,252,334,385],"monitoring":[29],"for":[30,64,82,143,146,191],"recurrence":[31,103,145,328],"after":[32,104,206],"curative":[33,207],"intent":[34,208],"treatment.":[35],"Utilizing":[36],"patient-specific":[37,187],"genomic":[38],"mutation":[39],"profiling":[40],"an":[42,111,224],"individual\u2019s":[43],"cancer":[44,184],"from":[45,71,233,236],"a":[46,58,65,76,97,168,186,254,388],"tissue":[47],"sample,":[48],"conjunction":[50],"patient\u2019s":[53,238,249],"germline":[54,242,250],"DNA,":[55,251],"create":[57],"personalized":[59],"sequencing":[60,273],"panel":[61],"analyze":[63],"subset":[66],"these":[68],"genetic":[69],"mutations":[70,232],"blood":[74],"is":[75,167,299],"strategy":[77],"that":[78,88,106,137,229],"high":[80,141],"sensitivity":[81,142],"detecting":[83,144],"MRD.":[84],"Studies":[85],"have":[86],"shown":[87,120],"pretreatment":[89],"levels":[90],"using":[93,185,274],"this":[94,138,285],"approach":[95,139],"are":[96,195,312],"potential":[98],"early":[99,112,181],"indicator":[100],"surgery,":[105],"clearance":[108],"may":[109],"be":[110,221,294],"predictor":[113],"favorable":[115],"outcomes":[116],"correlate":[122,314],"pathologic":[124,318],"complete":[125,319],"(Forde":[127],"et":[128,157],"al.":[129,158],"N":[130],"Engl":[131],"J":[132],"Med.":[133],"2022,":[134],"PMID:35403841),":[135],"advance":[149],"current":[152],"standard":[153,331],"care":[155],"(Abbosh":[156],"Cancer":[159,277,404,415],"Res":[160,416],"(2020)":[161],"80":[162],"(16_Supplement):":[163],"CT023).":[164],"Methods:":[165],"This":[166],"multi-site,":[169],"prospective,":[170],"observational":[171],"trial":[172,352],"United":[175],"States":[176],"200":[178],"stage":[182],"breast":[183],"tumor-informed":[188,226],"MRD":[189,227,287,305,315,338,381],"assay":[190,228,288],"analysis.":[193],"Participants":[194],"asked":[196],"provide":[198],"study":[199],"specimens":[200,268],"prior":[201],"initial":[203],"treatment":[204],"intervention,":[205],"surgical":[209],"resection,":[210],"during":[211],"adjuvant":[212],"(as":[214],"applicable)":[215],"pre-recurrence":[217],"follow-up.":[218],"will":[220,269,293],"analyzed":[222],"NGS-based,":[225],"identifies":[230],"somatic":[231],"DNA":[234],"obtained":[235],"tumor":[239,267,389],"tissue,":[240],"subtracts":[241],"variants":[243],"via":[244,387],"NGS-based":[245],"analysis":[246],"detects":[253],"selected":[255],"set":[256],"between":[258],"18-50":[259],"tumor-specific":[260],"their":[263],"blood.":[264],"All":[265],"primary":[266,297],"undergo":[270],"full":[271],"exome":[272],"Personalized":[276],"Monitoring":[278],"(PCM)":[279],"assay.":[280],"Impact":[281],"results":[283],"CLIA-approved":[286],"on":[289],"clinical":[290],"decision":[291],"making":[292],"captured.":[295],"The":[296],"objective":[298],"assess":[301],"ability":[303],"predict":[307],"post-treatment":[308],"recurrence.":[309],"Further":[310],"objectives":[311],"status":[316,339],"response,":[320],"determine":[321],"lead":[323],"time":[324],"detection":[326],"compared":[329],"care,":[333],"association":[336],"overall":[341],"survival.":[342],"Active":[343],"enrollment":[344],"started":[345],"March,":[347],"2022.":[348],"Support:":[349],"Invitae.":[350],"Clinical":[351],"information:":[353],"NCT05219734.":[354],"Citation":[355],"Format:":[356],"Edward":[357],"Esplin,":[358],"Kelli":[359],"Swan,":[360],"Lee":[361],"Ifhar,":[362],"Brandie":[363],"Heald,":[364],"Sarah":[365],"Nielsen,":[366],"Daniel":[367],"Pineda-Alvarez,":[368],"William":[369],"O'Callaghan,":[370],"Robert":[371],"Daber,":[372],"Darrel":[373],"Ross,":[374],"Carlos":[375],"Vieira,":[376],"Aadel":[377],"Chaudhuri,":[378],"W.":[379],"Korn.":[380],"Assay":[382],"evaluates":[383],"Recurrence":[384],"Informed":[390],"Assessment:":[391],"MARIA-Breast":[392],"Observational":[393],"Trial":[394],"[abstract].":[395],"In:":[396],"Proceedings":[397],"2023":[400,406],"San":[401,409],"Antonio":[402],"Breast":[403],"Symposium;":[405],"Dec":[407],"5-9;":[408],"Antonio,":[410],"TX.":[411],"Philadelphia":[412],"(PA):":[413],"AACR;":[414],"2024;84(9":[417],"Suppl):Abstract":[418],"nr":[419],"PO3-19-06.":[420]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-05-03T00:00:00"}